Geneos Wealth Management Inc. Can Fite Bio Pharma Ltd. Transaction History

Geneos Wealth Management Inc.

  • $2.77 Billion
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

May 19, 2021
SELL
$1.66 - $2.15 $1,105 - $1,431
-666 Closed
0 $0
Q3 2020

Sep 07, 2021
BUY
$1.61 - $2.67 $1,072 - $1,778
666 New
666 $1,000

Others Institutions Holding CANF

# of Institutions
2
Shares Held
1.1K
Call Options Held
0
Put Options Held
0
View Full List

About Can-Fite BioPharma Ltd.

CANF Quotes by TradingView
  • Ticker CANF
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,191,500
  • Market Cap $37M
  • Description
  • Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinic...
More about CANF
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email